HROW vs XERS
Comparison between Harrow Inc (HROW, Company) and Xeris Biopharma Holdings Inc (XERS, Company).
Both HROW and XERS are from the Healthcare sector.
5-Year PerformanceHROW has outperformed XERS, delivering a return of +33.9% compared to +29.1%
HROW vs XERS - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
HROW vs XERS - Historical Returns
Returns include dividend reinvestment.
HROW vs XERS - Annual Returns (2007 - 2026)
Returns include dividend reinvestment.
| Year | HROW | XERS |
|---|---|---|
| 2026 | -22.12% | +13.33% |
| 2025 | +34.03% | +126.88% |
| 2024 | +180.75% | +49.67% |
| 2023 | -24.22% | +109.82% |
| 2022 | +70.44% | -52.67% |
| 2021 | +17.55% | -44.82% |
| 2020 | -6.03% | -26.57% |
| 2019 | +51.07% | -59.71% |
| 2018 | +228.90% | -15.92% |
| 2017 | -31.17% | N/A |
| 2016 | -63.24% | N/A |
| 2015 | -8.09% | N/A |
| 2014 | +107.76% | N/A |
| 2013 | -61.60% | N/A |
| 2012 | +204.69% | N/A |
| 2011 | -84.81% | N/A |
| 2010 | -45.52% | N/A |
| 2009 | +50.00% | N/A |
| 2008 | -63.64% | N/A |
| 2007 | -8.33% | N/A |
HROW vs XERS Drawdown Comparison
The maximum drawdown for HROW was -99.46%, occurring on Mar 19, 2012. This drawdown has not yet recovered.
The maximum drawdown for XERS was -96.22%, occurring on Jan 5, 2023. This drawdown has not yet recovered.
The current HROW drawdown is -71.83%. The current XERS drawdown is -69.41%.
| Rank | HROW | XERS |
|---|---|---|
| #1 | -99.46% Oct 4, 2007 - Mar 19, 2012 | -96.22% Sep 10, 2018 - Jan 5, 2023 |
| #2 | N/A | -17.12% Jul 24, 2018 - Aug 14, 2018 |
| #3 | N/A | -10.98% Jun 21, 2018 - Jul 20, 2018 |
| #4 | N/A | -7.87% Aug 14, 2018 - Aug 22, 2018 |
| #5 | N/A | -3.41% Aug 23, 2018 - Sep 7, 2018 |
| #6 | N/A | -3.07% Jul 20, 2018 - Jul 24, 2018 |
Correlation
Correlation between HROW and XERS is -0.14 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks